CopyPastehas never been so tasty!

The Pharmaceutical Market : Japan

by anonymous

  • 0
  • 0
  • 0
53 views


OVERVIEW OF THE PHARMACEUTICAL MARKET IN JAPAN

Espicom projects that the Japanese pharmaceutical market will experience a slight CAGR contraction in dollar terms between 2012 and 2017. Japan will be the second largest pharmaceutical market in the Asia Pacific region, having been overtaken by China in 2016. Japan has a growing elderly population and in 2017 it is expected to be the largest in percentage terms in the Asia Pacific region, at over a quarter of the population. This will put enormous pressure on the government’s healthcare budget. Japan will also rank as the country with the second largest total health expenditure and third highest per capita health spending in the Asia Pacific region in 2017, due to its large population of over 65 years old that creates a high demand for pharmaceuticals. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/the-pharmaceutical-market-japan.html

The government and MHLW have sought to increase generic drugs usage to around 30% in 2012. From the experience of other countries, this would imply a sales value level of roughly 10%, should the volume target be reached. The Japan Generic Medicines Association estimates that generic drugs sales accounted for just under 10% of pharmaceutical sales by value and nearly a quarter of pharmaceutical sales by volume in 2011. There were a number of competitive strategies completed in the second half of 2011: Teva acquired Kowa’s 50% stake in the Teva-Kowa Pharma JV; Teva completed its acquisition of Taiyo; and Fujifilm and Dr Reddy's Laboratories signed a MoU to establish a JV.

Takeda is the largest Japanese pharmaceutical manufacturer in terms of sales, and has been by a considerable margin for some time. Other leading domestic producers include Astellas, Daiichi Sankyo and Eisai. Over the past five years, the fastest growing pharmaceutical companies have been Mitsubishi Tanabe Pharma, Dainippon Sumitomo Pharma, Kyowa Hakko Kirin Company, Shionogi & Co Ltd. and Otsuka. The leading foreign pharmaceutical companies in terms of sales in Japan are Pfizer, Roche and Novartis. A number of multinational companies are actively seeking to expand their operations in Japan, notably Pfizer, GlaxoSmithKline, Novartis and Bristol-Myers Squibb.

PROVIDING STRATEGIC MARKET ANALYSIS EVERY MONTH
Espicom's highly-regarded world pharmaceutical market research reports provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Market size and trends impacting the development of the market.
Five-year projections for market indicators such as health spending.
Regulations on drug applications & approvals, pricing & reimbursement as well as wholesaling and retail.
Specialised intelligence on generics and biological medicines.
Foreign and local company profiles


EXECUTIVE SUMMARY. 1
Snapshot: Strategic Espicom Analysis..2
Snapshot: Key Data Projections..3
MACROENVIRONMENT .... 4
POLITICAL4
ECONOMIC...5
Projections...5
LEGAL..6
Data Exclusivity6
DEMOGRAPHIC7
Projections...7
Latest Figures....8
Demographic Indicators.8
Births.... 8
Deaths. 8
Infant Deaths 8
Life Expectancy at Birth. 8
EPIDEMIOLOGY.. 9
DISEASE BURDEN..9
Leading Causes of Mortality9
DISEASE PREVALENCE....9
Communicable Diseases.9
HIV/AIDS... 9
Non-communicable Diseases...9
Cancer.. 9
Diabetes... 9
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS... 10
ORGANISATION...10
Health Insurance.10
EXPENDITURE.11
Projections.11
Latest Figures..12
INFRASTRUCTURE....12
Inpatient Analysis12
Outpatient Analysis.12
SERVICES12
Inpatient Analysis12
Outpatient Analysis.13
WORKFORCE...13
Projections.13
Latest Figures..14
REGULATORY AFFAIRS... 15
NATIONAL AUTHORITY15
REGULATORY DEVELOPMENTS.15
MARKETING REGISTRATION..15
Clinical Trials/GCP16
Drug Lag17
NCE Approvals17
POST-MARKETING SURVEILLANCE18
Re-examination...18
Periodic Safety Reporting .18
Re-evaluation.18
ADR Reporting18
LABELLING & PACKAGING19
PROMOTION...19
Advertising 19
PRICING & REIMBURSEMENT... 20
PRICING 20
Price Reductions..20
REIMBURSEMENT ... 20
National Health Insurance Drug Price List20
DISTRIBUTION CHANNELS.. 21
DRUG WHOLESALING...21
Trade Association 21
JPWA.. 21
Selected Wholesalers....22
Mediceo Corporation....22
Mitsubishi Logistics.22
Suzuken..22
DRUG RETAILING 22
Trade Association23
JACDS.23
Selected Pharmacy Chains23
Cocokara23
Matsumotokiyoshi...23
MARKET ANALYSIS 24
SIZE....24
Projections.24
Historical Figures.26
PRODUCT DEVELOPMENT26
MANUFACTURING....27

For more information kindly visit :
The Pharmaceutical Market : Japan

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/

Add A Comment: